PubMed Health⌕ Search

Biomedical subjects

K Schroader

Publications and source records attributed to K Schroader.

2 recordsLinked to original sources

An intercomparison between two methods of obtaining percentage depth doses for irregular shaped fields and comparison of each method with experimental data for 60Co and 10 MV X rays.

Measurements of central ray tissue-air ratio (TAR) for 60Co for a large number of irregularly shaped fields typically encountered in the cancer clinic were compared with TAR values either calculated by the Clarkson method using scatter air ratios or obtained from tables of square field data using the area/perimeter approach. Irregular field shapes included the "L", pentagonal, rectangular, upper and lower mantle and split fields. Agreement between both calculational methods and direct measurement is within +/- 2% if careful attention is given to central ray position as affected by the proper use of off-centre ratios in air. In the case of 10 MV X-rays, eight randomly chosen irregular fields again yielded an average agreement between both methods of calculation and experimental data of less than 1% and an agreement of less than 0.5% between the A/P and Clarkson calculations.

Cobalt Radioisotopes↗

Method for localizing and calculating vaginal dose in brachytherapy.

Contrast agents in the vagina are being used to determine the position of vaginal surfaces relative to applicators in an effort to assess dose at these sites. Computer treatment planning allows consideration of dose at many more sites than was formerly possible, but dose prescription to critical tumor volumes then becomes of greater importance. Vaginal reference dose points VR, VL, VA, and VP are proposed. With dose specification determined at these points, the problem of low vaginal dose from overly wide vaginal ovoid geometries and related difficulties can be avoided. Attention to central vaginal doses can reduce the probability of central pelvic recurrence in the vagina. We have found the VR, VL doses were much larger than VA, VP doses in standard loaded implant configurations.

Aged↗